This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: DIAGBI
DIAGBI: Theranostics of brain tumors using immuno-radiopharmaceuticals and nanotechnology
November 17, 2021María José Alonso’s Lab participates in the DIAGBI project for the early and non-invasive diagnosis of brain tumors. The main objective of DIAGBI is to develop a new technology that allows early diagnosis and non-invasive monitoring of the most aggressive brain tumors, glioblastomas, using immuno-PET techniques.
Read More